A Novel Oral Natural Extract for the Treatment of Senile Purpura

Nexgen Dermatologics, Inc.75 enrolled

Overview

A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Enrollment

Conditions

PURPURA

Interventions

Citrus Bioflavanoid BlendDIETARY_SUPPLEMENT

Pill Taken Twice a Day

Calcium CarbonateDIETARY_SUPPLEMENT

Oral Tablet Taken Twice a Day

Eligibility

Sex: ALLMin age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with evidence of purpura on physical exam Exclusion Criteria: * Preexisting condition that would not allow the patients to take oral calcium supplement

Locations (1)

Berlin Center of Medical Aesthetics

Boynton Beach, Florida, United States

Outcomes

Primary Outcomes

IMPROVEMENT IN PATIENT'S SKIN APPEARANCE WITH SENILE PURPURA

Time frame: 6 WEEKS

Secondary Outcomes

ADVERSE EFFECTS IN PATIENTS WITH SENILE PURPURA TAKING THIS MEDICATION

Time frame: 6 WEEKS

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.